Kontour Medical(SH:688314) Xin Lang Cai Jing·2025-08-28 02:37Group 1 - The core point of the news is that Kangtuo Medical experienced a decline of 5.15% in its stock price, reaching 37.17 yuan per share, with a total market capitalization of 3.02 billion yuan [1] - Kangtuo Medical, established on March 14, 2005, and listed on May 18, 2021, specializes in the research, production, and sales of three types of implantable medical devices [1] - The revenue composition of Kangtuo Medical includes 63.94% from PEEK material neurosurgical products, 22.42% from titanium material neurosurgical products, 10.47% from other products, and 3.18% from supplementary products [1] Group 2 - According to data, a fund under Jianxin Fund holds a significant position in Kangtuo Medical, with Jianxin Flexible Allocation Mixed A (000270) owning 106,700 shares, representing 1.18% of the fund's net value [2] - The Jianxin Flexible Allocation Mixed A fund has a total scale of 112 million yuan and has achieved a return of 49.44% this year, ranking 464 out of 8190 in its category [2] - The fund has also seen a remarkable return of 99.9% over the past year, ranking 298 out of 7966 in its category, and a cumulative return of 152.36% since its inception [2] Group 3 - The fund manager of Jianxin Flexible Allocation Mixed A is Ye Letian, who has a tenure of 13 years and 164 days, with the fund's total asset scale at 6.53 billion yuan [3] - During Ye Letian's tenure, the best fund return was 241.01%, while the worst was -18.94% [3] - The co-manager, Guo Zhiteng, has a tenure of 1 year and 266 days, managing a fund scale of 625 million yuan, with a best return of 155.31% and a worst return of 12.27% during his tenure [3]